FIRE Funds Income Target ETF FIRI 深 滬
已收盤 08-01 16:00:00 美东时间
18.95
+0.015
+0.08%
華盛通- 最 高18.95
- 今 開18.935
- 成交量 52股
- 最 低 18.95
- 昨 收 18.935
- 總市值 123.18万
- 52周最高 19.3204
- 市盈率 靜 --
- 換手率 0.08%
- 52周最低 18.0365
- 委 比 0.00%
- 總股本 6.50万
- 歷史最高 18.95
- 量 比 0
- 振 幅 0.00%
- 歷史最低 18.1169
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Is Micro-Cap AIM ImmunoTech Stock Surging?
AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer patients.
07-28 23:12
AIM ImmunoTech Announces Mid-Year Data From Phase 2 DURIPANC Trial Of Ampligen And AstraZeneca's Imfinzi In Metastatic Pancreatic Cancer Patients Post-FOLFIRINOX
AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today reported positive data in a mid-year update from the ongoing Phase 2 clinical study evaluating AIM's drug Ampligen® (rintatolimod) combined with
07-28 21:03
Xenetic Biosciences Announces First Patient Dosing In Exploratory Clinical Study Of Systemic DNase I In Combination With FOLFIRINOX For Advanced Or Metastatic Pancreatic Cancer
Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNessCompany evaluating systemic recombinant human DNase I (DNase I) in combination with
07-08 21:04
石药集团现涨近4% 同意授予Cipla在美销售伊立替康脂质体注射液独家许可
石药集团（01093）股价现涨3.68%，现报5.92港元，成交额2.03亿港元。 5月15日，石药集团发布公告，集团已与Cipla USA， Inc．（...
05-16 10:57
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the fi...
05-02 04:01
FDA批准百时美施贵宝(BMY.US)Opdivo+Yervoy联合治疗结直肠癌
百时美施贵宝表示，FDA已批准其重磅PD-1抑制剂Opdivo联合CTLA-4靶向抗体Yervoy用于治疗MSI-H或dMMR表型的转移性结直肠癌(mCRC)成人和儿童患者。
04-09 14:48
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, March 8, 2025 /PRNewswire/ -- As the global cancer crisis intensifies, the demand for breakthrough t...
03-08 20:33
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 27, 2025 /PRNewswire/ -- USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has com...
02-27 23:04
复星医药(600196.SH)：控股子公司收到药品用于治疗RAS突变转移性结直肠癌临床试验的批准
2025年2月27日，复星医药(600196.SH)公告称，控股子公司江苏星盛新辉医药有限公司收到国家药品监督管理局关于同意XS-03片与FOLFOX或FOL...
02-27 17:22
